Fully Integrated Platform For COVID-19 IVD Medical Device

Fully Integrated Platform for COVID-19

The employment of a single system to execute all functions that are capable of being accomplished by the combination of numerous systems is an example of fully integrated automation. This system has the potential to make operations much easier, make them less reliant on the expert experimental environment, and use fully integrated automation to avoid failures in experiments caused by human error.

Types Of Fully Integrated Platform for COVID-19

SARS-CoV-2 Integrated Microfluidic Chip Analysis System

The system, adopting two cutting-edge technologies, provides a “samples in, answers out”testing mode within 45 mins, including sample lysis, nucleic acid extraction, on-chip nested isothermal amplification, and fluorescence detection.

COVID-19 Mobile Laboratory

Combined with global leading chip laboratory technology and swab robot sampling technology, COVID-19 Mobile Laboratory can achieve “samples in, answers out”susceptible and rapid detection in various demand scenarios, such as border ports, CDC, grassroots hospitals, etc.

Cabin Laboratory

The laboratory is convenient to transport and has complete functions. After collecting samples, they can be tested on the spot, which reduces the time for sample circulation.

Related CapitalBio Health Solutions

Solutions for Infectious Disease Control

CapitalBio provides comprehensive control solutions for infectious diseases, such as Respiratory Pathogens related diseases and Tuberculosis Bacteria related diseases, in order to assist clinicians in formulating precise diagnoses and treatment plans.

Solutions for Maternal and Child Healthcare

Based on the powerful testing platform and independent research and development capabilities, CapitalBio formed a congenital disability prevention and control program including NIPT, NIPT-PLUS, CNV-seq, and Deafness-related Gene Mutation detection, escort for the health of women and children.

Solutions for Anti-cancer Therapy

The new model of cancer diagnosis and treatment is genetic testing combined with targeted therapy, which will enhance both the effective rate and overall survival of cancer patients. CapitalBio anti-cancer solutions cover all stages of cancer development, from diagnosis to treatment to prognosis.

Solutions for Pharmacogenomics

Based on pharmacogenomics, Pharmacogenomics Testing makes prescription safer and more effective by detecting genes associated with drug metabolism, efficacy, and side effects. Given the stability of genes and the irreversibility of the impact of many ADRs, the test would benefit the entire life.

Solutions for Precise Healthcare Management

Combined with modern technology, traditional Chinese medicine diagnoses patients effectively and guides them to live healthy lives.